Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Boike

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
British Journal of Clinical Pharmacology|October 9, 1998
Effect of age and gender on the pharmacokinetics of eprosartanD M Tenero, D E Martin, A K Miller, et al.
Journal of Clinical Pharmacology|August 1, 1996
Pharmacokinetics of testosterone in hypogonadal men after transdermal delivery: influence of doseD R Brocks, A W Meikle, S C Boike, et al.
Journal of Clinical Pharmacology|May 23, 1998
A dose proportionality study of eprosartan in healthy male volunteersM C Chapelsky, D E Martin, D M Tenero, et al.
Journal of Clinical Pharmacology|December 1, 1994
Pharmacokinetics of famciclovir in subjects with chronic hepatic diseaseS C Boike, M Pue, P R Audet, et al.
Journal of Clinical Pharmacology|February 1, 1997
Eprosartan, an angiotensin II receptor antagonist, does not affect the pharmacodynamics of glyburide in patients with type II diabetes mellitusD E Martin, G S DeCherney, B E Ilson, et al.
Clinical Pharmacology and Therapeutics|November 14, 1997
Effect of fluconazole on the pharmacokinetics of eprosartan and losartan in healthy male volunteersD J Kazierad, D E Martin, R A Blum, et al.
Clinical Pharmacy|September 1, 1983
Evaluation of a method for intravenous phenytoin infusionS C Boike, M J Rybak, J E Tintinalli, et al.
Clinical Pharmacology and Therapeutics|April 1, 1994
Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairmentS C Boike, M A Pue, M I Freed, et al.
Journal of Clinical Pharmacology|August 6, 1999
The effect of low-dose cimetidine (200 mg twice daily) on the pharmacokinetics of theophyllineD E Nix, R A Di Cicco, A K Miller, et al.
The Annals of Pharmacotherapy|April 9, 1998
Effect of ranitidine on the pharmacokinetics of orally administered eprosartan, an angiotensin II antagonist, in healthy male volunteersD M Tenero, D E Martin, B E Ilson, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
British Journal of Clinical Pharmacology|October 9, 1998
Effect of age and gender on the pharmacokinetics of eprosartanD M Tenero, D E Martin, A K Miller, et al.
Journal of Clinical Pharmacology|August 1, 1996
Pharmacokinetics of testosterone in hypogonadal men after transdermal delivery: influence of doseD R Brocks, A W Meikle, S C Boike, et al.
Journal of Clinical Pharmacology|May 23, 1998
A dose proportionality study of eprosartan in healthy male volunteersM C Chapelsky, D E Martin, D M Tenero, et al.
Journal of Clinical Pharmacology|December 1, 1994
Pharmacokinetics of famciclovir in subjects with chronic hepatic diseaseS C Boike, M Pue, P R Audet, et al.
Journal of Clinical Pharmacology|February 1, 1997
Eprosartan, an angiotensin II receptor antagonist, does not affect the pharmacodynamics of glyburide in patients with type II diabetes mellitusD E Martin, G S DeCherney, B E Ilson, et al.
Clinical Pharmacology and Therapeutics|November 14, 1997
Effect of fluconazole on the pharmacokinetics of eprosartan and losartan in healthy male volunteersD J Kazierad, D E Martin, R A Blum, et al.
Clinical Pharmacy|September 1, 1983
Evaluation of a method for intravenous phenytoin infusionS C Boike, M J Rybak, J E Tintinalli, et al.
Clinical Pharmacology and Therapeutics|April 1, 1994
Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairmentS C Boike, M A Pue, M I Freed, et al.
Journal of Clinical Pharmacology|August 6, 1999
The effect of low-dose cimetidine (200 mg twice daily) on the pharmacokinetics of theophyllineD E Nix, R A Di Cicco, A K Miller, et al.
The Annals of Pharmacotherapy|April 9, 1998
Effect of ranitidine on the pharmacokinetics of orally administered eprosartan, an angiotensin II antagonist, in healthy male volunteersD M Tenero, D E Martin, B E Ilson, et al.
Pageof 4